Quality Assessment of Oral Anticoagulation by Time in Therapeutic Range in Patients with Venous Thromboembolism in Korea
Authors:
Open Access
- 1 May 2019
- journal article
- Published by The Korean Society on Thrombosis and Hemostasis in Clinical & Experimental Thrombosis and Hemostasis
- Vol. 5 (1) , 8-10
Abstract
Purpose: To assess the efficacy and safety of oral anticoagulation with warfarin by time in therapeutic range in patients with venous thromboembolism (VTE) in South Korea. Methods: This was a retrospective, single-center study to evaluate patients diagnosed with VTE and managed with adjusted dose of warfarin over two-thirds of follow-up period in Thrombosis Clinic between February 2009 and August 2010. Validated dosing algorithm was used to manage the international normalized ratio (INR). Time in therapeutic range was calculated by Rosendaal method. Results: The period of predetermined warfarin interruption for peri-operative management (1 week preoperatively and 3 weeks post-operatively) was censored. It was not analyzed in 34 episodes. Out of 76 patients with VTE, 47 (23 men; mean age 64.9 years) were analyzed. Approximately two-thirds (31/47) of patients were warfarin-naïve. Total number of admissions was 84. Expected duration of anticoagulation was 6 months in 22 patients (47%), 12 months in 1 (2%), and indefinite in 24 (51%). There were various comorbidities, including active malignancy in 7 patients (15%), mycobacterium tuberculosis on rifampicin in 4 (8.5%), chronic kidney disease in 4 (8.5%), and hemorrhagic cerebral infarct in 1 (2%). Overall time in therapeutic range (TTR) was 52.4%. Most proportion of out-of-range was below the therapeutic range (29.5%). There was no thromboembolic complication, although two cases of major bleeding complications were observed. Conclusion: The validated dosing algorithm is effective for managing INRs in patients with VTE in Korea.Keywords
This publication has 10 references indexed in Scilit:
- Incidence of venous thromboembolism in Korea from 2009 to 2013PLOS ONE, 2018
- Efficacy and safety of edoxaban for treatment of venous thromboembolism: a subanalysis of East Asian patients in the Hokusai‐VTE trialJournal of Thrombosis and Haemostasis, 2015
- Effect of a simple two‐step warfarin dosing algorithm on anticoagulant control as measured by time in therapeutic range: a pilot studyJournal of Thrombosis and Haemostasis, 2010
- Pharmacology and Management of the Vitamin K AntagonistsChest, 2008
- Effect of Study Setting on Anticoagulation ControlChest, 2006
- Poor anticoagulation quality in the first 3 months after unprovoked venous thromboembolism is a risk factor for long‐term recurrenceJournal of Thrombosis and Haemostasis, 2005
- Is INR between 2.0 and 3.0 the optimal level for Chinese patients on warfarin therapy for moderate‐intensity anticoagulation?British Journal of Clinical Pharmacology, 2005
- Individual time within target range in patients treated with vitamin K antagonists: main determinant of quality of anticoagulation and predictor of clinical outcome. a retrospective study of 2300 consecutive patients with venous thromboembolismBritish Journal of Haematology, 2005
- Quality of Anticoagulation Management Among Patients With Atrial FibrillationArchives of internal medicine (1960), 2000
- A Method to Determine the Optimal Intensity of Oral Anticoagulant TherapyThrombosis and Haemostasis, 1993